Prophylactic Treatment Against GM-CSF, but Not IL-17, Abolishes Relapses in a Chronic Murine Model of Multiple Sclerosis

European Journal of Immunology - United Kingdom
doi 10.1002/eji.201847580
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

IL-22, GM-CSF and IL-17 in Peripheral CD4+ T Cell Subpopulations During Multiple Sclerosis Relapses and Remission. Impact of Corticosteroid Therapy

PLoS ONE
Multidisciplinary
2017English

Treatment of Acute Relapses in Multiple Sclerosis

2016English

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Turk Noroloji Dergisi
Neurology
2016English

Riboflavin May Ameliorate Neurological Motor Disability but Not Spatial Learning and Memory Impairments in Murine Model of Multiple Sclerosis

Clinical Nutrition Experimental
EndocrinologyNutritionMetabolismDieteticsDiabetes
2019English

Optic Neuritis and Retinal Ganglion Cell Loss in a Chronic Murine Model of Multiple Sclerosis

Frontiers in Neurology
Neurology
2011English

Gm-CSF

2018English

Atenolol, but Not Mexiletine, Protects Against Stimulus-Induced Ventricular Tachycardia in a Chronic Canine Model

British Journal of Pharmacology
Pharmacology
1989English

Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in CSF Are Not a Valuable Biomarker for Multiple Sclerosis

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2018English

Prophylactic Treatment of Osteoporosis After SCI: Promising Research, but Not Yet Indicated

Spinal cord series and cases
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy